Combined Biologics and Exclusive Enteral Nutrition Promote Early Transmural Healing and Improve Long‐Term Outcomes in Crohn’s Disease: A Multicenter Retrospective Study
Clinical Pharmacology & Therapeutics · 2025
DOI: 10.1002/cpt.70034 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025. Verfasst von Haixia Ren und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Crohn Disease, Enteral Nutrition, Biological Products, Wound Healing. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Transmural healing (TH), a comprehensive therapeutic target in Crohn’s disease (CD), is associated with reduced long‐term complications. However, evidence on the role of exclusive enteral nutrition (EEN) in TH remains limited. This study aimed to evaluate the efficacy of biologics combined with 16‐week EEN in achieving early TH and improving clinical outcomes. This real‐world, multicenter retrospective study analyzed medical records of patients with moderate‐to‐severe CD from 2016 to 2024. Patients received either biologics with concomitant 16‐week EEN (BioEEN) or biologics alone (Bio). Clinical and endoscopic outcomes, including transmural healing, were assessed at week 16, year 1, and year 2. At baseline, demographic and clinical characteristics were comparable between the two groups. The BioEEN group demonstrated superior clinical response rates compared to the Bio group (95.1% vs. 70.6% at week 16; P < 0.001), with sustained benefits at week 52 (87.8% vs. 59.5%; P < 0.001). Subgroup analysis revealed higher endoscopic response, mucosal healing, and TH rates in both colorectal and ileal segments at weeks 16 and 52 in the BioEEN group. Additionally, the BioEEN group had significantly lower rates of surgery, escalated treatment, bowel damage progression, and disease relapse at 1 and 2 years. Regression analysis identified the 16‐week EEN as the sole protective factor for early transmural healing and improved long‐term outcomes. Combined treatment of biologics and 16‐week EEN promotes early transmural healing, thereby enhancing long‐term clinical outcomes in CD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Key Laboratory of Hubei Province for Digestive System Disease, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Hubei Provincial Clinical Research Center for Digestive Disease Minimally Invasive Incision, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Nursing, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Gastroenterology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
- Department of Radiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
ORCID-Profile: Haixia Ren, Jing An, Wei Chen, Jiao Li, Anning Yin, Jing Wang, Jian Kang, Yueyue Lu, Juan Su, Ping An
Zitieren
APA
Ren, H., An, J., Chen, W., Li, J., Li, X., Yin, A., Wang, J., Wang, W., Cheng, J., Kang, J., Xu, Y., Lu, Y., Su, J., Zhou, Q., Wan, H., Zhang, Z., & An, P. (2025). Combined Biologics and Exclusive Enteral Nutrition Promote Early Transmural Healing and Improve Long‐Term Outcomes in Crohn’s Disease: A Multicenter Retrospective Study. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70034
Vancouver
Ren H, An J, Chen W, Li J, Li X, Yin A, et al. Combined Biologics and Exclusive Enteral Nutrition Promote Early Transmural Healing and Improve Long‐Term Outcomes in Crohn’s Disease: A Multicenter Retrospective Study. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.70034
BibTeX
@article{Ren2025,
author = {Ren, Haixia and An, Jing and Chen, Wei and Li, Jiao and Li, Xing and Yin, Anning and Wang, Jing and Wang, Wei and Cheng, Jingyun and Kang, Jian and Xu, Yaqing and Lu, Yueyue and Su, Juan and Zhou, Qian and Wan, Huipeng and Zhang, Zimeng and An, Ping},
title = {Combined Biologics and Exclusive Enteral Nutrition Promote Early Transmural Healing and Improve Long‐Term Outcomes in Crohn’s Disease: A Multicenter Retrospective Study},
journal = {Clinical Pharmacology & Therapeutics},
year = {2025},
doi = {10.1002/cpt.70034}
}
EUVIMED